Indeed, recent evidence indicates that the extent of B cell infiltration is the strongest positive prognostic factor in patients with STS, even in cases with low CD8+ T cell infiltration [139], suggesting that the immunogenicity of some sarcomas may be driven by B lymphocytes. This evidence concerns the gene CD8A and telomere syndrome.